Peter Hirth
Director at Aligos Therapeutics, Inc. (ALGS)
Peter Hirth has filed 16 insider reports with the SEC since June 2021, as director at Aligos Therapeutics, Inc. (ALGS), director at IO Biotech, Inc. (IOBT) and director at Vaxcyte, Inc. (PCVX). The latest filing, on June 29, 2026, reports grant or award at Aligos Therapeutics, Inc. (ALGS).
- Filings
- 16
- Companies
- 3
- Bought on market
- None
- Sold on market
- None
Companies where Peter Hirth is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | $1.22 | Jun 29, 2026 | |||||
| Director | Jun 6, 2025 | ||||||
| Director | 7,175 | $55.39 | Jun 10, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 25, 2026ALGSSEC Form 4 filed by Director Hirth PeterForm 4Grant or award
- Jun 25, 2025ALGSSEC Form 4 filed by Director Hirth PeterForm 4Grant or award
- Jun 5, 2025IOBTSEC Form 4 filed by Director Hirth PeterForm 4Grant or award
- Jun 27, 2024ALGSSEC Form 4 filed by Director Hirth PeterForm 4Grant or award
- Jun 6, 2024PCVXDirector Hirth Peter was granted 1,550 shares, increasing direct ownership by 28% to 7,175 unitsForm 4Grant or award
- Jun 6, 2024IOBTSEC Form 4 filed by Hirth PeterForm 4Grant or award
- Feb 28, 2024ALGSSEC Form 4 filed by Hirth PeterForm 4Grant or awardSale back to the company
- Jul 20, 2023ALGSSEC Form 4 filed by Hirth PeterForm 4Grant or award
- Jun 13, 2023PCVXSEC Form 4 filed by Hirth PeterForm 4Grant or award
- Jun 8, 2023IOBTSEC Form 4 filed by Hirth PeterForm 4Grant or award
- Jun 23, 2022ALGSSEC Form 4 filed by Hirth PeterForm 4Grant or award
- Jun 1, 2022PCVXSEC Form 4: Hirth Peter was granted 3,125 sharesForm 4Grant or award
- May 26, 2022IOBTSEC Form 4 filed by Hirth PeterForm 4Grant or award
- Nov 4, 2021IOBTSEC Form 4 filed by Hirth PeterForm 4Grant or award
- Jun 17, 2021ALGSSEC Form 4 filed by Hirth PeterForm 4Grant or award
- Jun 2, 2021PCVXSEC Form 4 filed by Hirth PeterForm 4Grant or award
Also sits on boards with
Officers and directors who share two or more companies with Peter Hirth.
Compare Peter Hirth with
- Peter Hirth vs Jack Nielsen2 shared
- Peter Hirth vs Harpreet S. Dhaliwal1 shared
- Peter Hirth vs Elvia Cowan1 shared
- Peter Hirth vs Jim Wassil1 shared
- Peter Hirth vs Grant Pickering1 shared
- Peter Hirth vs Andrew Guggenhime1 shared
Other insiders at the same companies
- Harpreet S. DhaliwalPCVX
- Elvia CowanPCVX
- Jim WassilPCVX
- Grant PickeringPCVX
- Andrew GuggenhimePCVX
- Luis JodarPCVX
- John MarkelsPCVX
- Heather PrestonALGS
- Margarita ChavezALGS
- Bridget A MartellALGS
- James Paul ScopaALGS
- Carole NuechterleinALGS
- Moncef SlaouiPCVX
- Carlos V PayaPCVX
- Olivier BrandicourtPCVX
- John FureyPCVX
Questions about Peter Hirth
- What is Peter Hirth's role at Aligos Therapeutics, Inc.?
- Peter Hirth reports to the SEC as director at Aligos Therapeutics, Inc. (ALGS), according to the latest filing on June 29, 2026. Peter Hirth has also filed as director at IO Biotech, Inc. (IOBT) and director at Vaxcyte, Inc. (PCVX).
- How many shares does Peter Hirth own?
- After the latest filing that states it, Peter Hirth directly owned 7,175 shares of Vaxcyte, Inc. (PCVX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Peter Hirth bought or sold stock recently?
- No open-market purchases or sales by Peter Hirth are on file. The filings report grant or award and sale back to the company.
- How do I get alerts when Peter Hirth files?
- Follow Peter Hirth on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Peter Hirth (SEC CIK 0001813780). Totals count each trade once, skipping amendments whose original is on file, from Jun 3, 2021 on. View on SEC EDGAR · Get this as JSON